Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001373604-26-000076·LENZ Therapeutics, Inc.
Schedule 13G ownership disclosure
LENZ THERAPEUTICS INC
Common Stock, $0.00001 par value per share · CUSIP: 52635N103
Event date: 2026-11-02
- Filing-level shares
- 2,110,727
- Percent of class
- 6.7%
- BML Investment Partners, L.P.
Shares: 2,110,727 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-26-000076
- Form type
- SCHEDULE 13G
- Filer
- LENZ Therapeutics, Inc.
- CIK
- CIK 1815776
- Filed
- Nov 04, 2026
- Reporting period
- Nov 02, 2026
- Description
- Schedule 13G beneficial ownership